BTIG Maintains Buy on Aura Biosciences, Raises Price Target to $24

Benzinga · 10/18 14:44
BTIG analyst Robert Hazlett maintains Aura Biosciences (NASDAQ:AURA) with a Buy and raises the price target from $21 to $24.